Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

LYELLYEL
5 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in LYELL IMMUNOPHARMA INC

TWO SIGMA INVESTMENTS, LP holds 52,927 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $743,624 as of 2026-Q2. The position was increased (+356.9% shares). LYEL represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$743,624

Current Shares

52,927

Total Value Change

+$654,702

Total Shares Change

+42,868

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
52,927
+356.9%
$743,6240.0%$14.05
40
2026-Q1
Decreased
11,585
-25.8%
$232,3950.0%$23.33
0
2025-Q4
Decreased
15,616
-25.0%
$480,6600.0%$31.59
0
2025-Q3
Increased
20,827
+107.0%
$338,2300.0%$14.97
38
2025-Q2
New
10,059
-
$88,9220.0%$8.94
30

Other major holders of LYEL: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used